Stockscreener 앱 받기
10.88
37.90%
2.99
전일 마감가:
$7.89
열려 있는:
$8.38
하루 거래량:
6.01M
Relative Volume:
2.19
시가총액:
$11.76M
수익:
$31,800
순이익/손실:
$-37.83M
주가수익비율:
-15.32
EPS:
-0.71
순현금흐름:
$-30.64M
1주 성능:
+158.43%
1개월 성능:
+601.94%
6개월 성능:
+44.37%
1년 성능:
-80.35%
1일 변동 폭
$8.04
$12.37
1주일 범위
$4.57
$12.37
52주 변동 폭
$0.85
$124.80
Eyenovia Inc Stock (EYEN) Company Profile
명칭
Eyenovia Inc
전화
813-766-9539
주소
295 MADISON AVENUE,, NEW YORK, NY
EYEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
10.88 | 11.76M | 31,800 | -37.83M | -30.64M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-03-01 | 개시 | Northland Capital | Outperform |
| 2020-02-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
Eyenovia Inc 주식(EYEN)의 최신 뉴스
HYPE Price Drops Below $40 Despite $50M Eyenovia Investment - The Currency analytics
Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings - The Malaysian Reserve
Eyenovia Bets On Crypto Hype To Revive Struggling Stock - FinanceFeeds
Eyenovia (EYEN) Advances Digital Strategy with Key Developments - GuruFocus
$50 Million Gamble or Genius Move? Eyenovia’s Big Blockchain Bet - Bitcoin.com News
Eyenovia (EYEN) Advances Digital Strategy with Key Developments | EYEN Stock News - GuruFocus
Eyenovia secures debt restructuring as it builds HYPE token treasury By Investing.com - Investing.com Nigeria
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group | EYEN Stock News - GuruFocus
Eyenovia appoints strategic advisor for digital asset treasury strategy - TipRanks
Eyenovia Announces Appointment of a Strategic Advisor for - GlobeNewswire
Eyenovia Secures Major Win: 33% Lower Interest Rate and Top Crypto Advisor Join Forces - Stock Titan
Hyperliquid price outlook amid Eyenovia’s $50M HYPE treasury strategy - CoinJournal
Top Premarket Decliners - MarketScreener
Eyenovia unveils $50M HYPE token strategy; shares drop - MSN
Eyenovia (EYEN) Secures $50 Million Private Placement for Blockchain Initiative - GuruFocus
Eyenovia to invest $50M in Hyperliquid tokens - MSN
Eyenovia Launches $50 Million HYPE Treasury, Announces Rebrand to Hyperion DeFi - BeInCrypto
Nasdaq-Listed Eyenovia Announces to Add $HYPE in Treasury Reserve - The Crypto Times
HYPE drops 6% amid Eyenovia plans to establish Hyperliquid treasury - FXStreet
Eyenovia (EYEN) Secures $50M to Boost Blockchain Initiative | EY - GuruFocus
Eyenovia Invests $50 Million to Establish HYPE Reserve, Company Will Change Name to 'Hyperion DeFi' - Binance
Eyenovia stock soars after $50 million investment for cryptocurrency strategy By Investing.com - Investing.com Nigeria
Eyenovia Inc Announces $50 Million Private Placement In Public Equity - marketscreener.com
Eyenovia (EYEN) Secures $50M Investment for Blockchain Expansion | EYEN Stock News - GuruFocus
Eyenovia to acquire $50 million in HYPE cryptocurrency tokens - Investing.com
Eyenovia to acquire $50 million in HYPE cryptocurrency tokens By Investing.com - Investing.com India
Eyenovia to change name to Hyperion DeFi, ticker to ‘HYPD’ - TipRanks
Eyenovia announces $50M PIPE financing to launch Hyperliquid reserve strategy - TipRanks
Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy | EYEN Stock News - GuruFocus
Eyenovia Announces $50 Million Investment to Launch a - GlobeNewswire
Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia - Ophthalmology Times
Eyenovia (EYEN) Stock Skyrockets Over 23% on Nasdaq, Showing Explosive Short-Term Rally - Daily Chhattisgarh News
Eyenovia (EYEN) Stock Explodes Following Amended Loan Agreement Terms: What's Going On? - Benzinga
eyenovia amends loan agreement, limits stock conversion option By Investing.com - Investing.com Canada
Eyenovia On May 30, Enters Third Amendment To Loan And Security AgreementSEC Filing - MarketScreener
eyenovia amends loan agreement, limits stock conversion option - Investing.com
Eyenovia Amends Loan Agreement with Avenue Capital - TipRanks
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities - GlobeNewswire Inc.
Larry Childress buying at Fireweed Metals (FWZ) - The Globe and Mail
Eyenovia provides update on potential merger and Optejet development - MSN
Eyenovia Provides Updates on Potential Merger with Betaliq and D - GuruFocus
Eyenovia Advances Merger Talks With Betaliq And Targets FDA Filing For Optejet Device - Nasdaq
Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Eyenovia Reports Q1 2025 Progress and Financials - TipRanks
Eyenovia advances on merger talks, cuts cash burn, eyes September FDA filing By Investing.com - Investing.com South Africa
Eyenovia advances on merger talks, cuts cash burn, eyes September FDA filing - Investing.com Australia
Eyenovia Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Eyenovia (EYEN) Pursues Merger with Betaliq and Advances Optejet Device | EYEN Stock News - GuruFocus
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results | EYEN Stock News - GuruFocus
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results - The Manila Times
Eyenovia, Inc. Provides Merger Update with Betaliq and Financial Results for Q1 2025 - Nasdaq
Eyenovia Inc (EYEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Eyenovia Inc 주식 (EYEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rowe Michael M | Chief Executive Officer |
Aug 26 '24 |
Buy |
0.57 |
50,000 |
28,500 |
82,927 |
| Grant Stuart M. | 10% Owner |
Jul 02 '24 |
Buy |
0.66 |
1,515,151 |
1,000,000 |
10,914,153 |
1.11%
1.70%
자본화:
|
볼륨(24시간):